Clinical Trials Logo

Clinical Trial Summary

This study intends to determine the incidence, risk factors and endoscopic treatment of proximally migrated pancreatic stents.


Clinical Trial Description

Endoscopic pancreatic stenting can be used to treat a variety of pancreatic disorders, including chronic pancreatitis-induced pancreatic duct stenosis, pancreatic schizophrenia, pancreatic leakage, pancreatic pseudocyst drainage, and prophylactic pancreatic duct stenting. Postoperative stent migration is one of the complications associated with pancreatic stent placement. In this retrospective study, more than 9,000 Endoscopic retrograde cholangiopancreatography (ERCP) cases at our center over the past 25 years will be analyzed to determine the incidence, risk factors and endoscopic treatment of proximally migrated pancreatic stents. ;


Study Design


NCT number NCT05431517
Study type Observational
Source Changhai Hospital
Contact
Status Completed
Phase
Start date June 30, 2022
Completion date July 31, 2022